Beta
189868

Assessing the Safety and Efficacy of Thoracoscopic Lung Biopsy in Patients with Interstitial Lung Disease

Article

Last updated: 04 Jan 2025

Subjects

-

Tags

Internal Medicine

Abstract

Background: Interstitial lung disease [ILD] is a difficult-to-treat disease. The patient continues treatment for his/her whole life. However, certain causes – when diagnosed - could change their treatment plan. Radiological investigations cannot elicit the underlying pathology 100%. Thus, transthoracic lung biopsy is of utmost importance, especially in undiagnosed patients. But, it is not free of risk, and thus, its use is still controversial.
Aim of the work: This work aims to evaluate the role of medical thoracoscopic lung biopsy [TLB] in diagnosing diffuse parenchymal lung diseases.
Patients and Methods: Fifty patients with diffuse lung infiltrate on high-resolution computed tomography [HCRT] of unconfirmed diagnosis were included. All patients have been submitted to detailed clinical examination and specific laboratory investigations. Furthermore, all had high resolution computed tomography, pulmonary function tests], echocardiography, arterial blood gas analysis, and bronchoalveolar lavage assessment. The thoracoscopic lung biopsy was performed under local anesthesia. The specimens were preserved in formalin containing cups till examination. Patients were followed up, and any complications were documented.
Results: The lung HCRT revealed ground-glass opacity [44%], reticulonodular interstitial pattern [38%], honeycombing [14%], crazy paving [10.0%], and consolidation [20.0%]. The histopathology revealed alveolar proteinosis [2.0%], alveolar hemosidrosis [2.0%], hypersensitivity pneumonitis [24.0%], sarcoidosis [8.0%], nonspecific interstitial pneumonia [20%], Idiopathic pulmonary fibrosis [12.0%], respiratory bronchiolitis ILD [18%], and desquamative ILD [14.0%]. All patients positive on HCRT had pathological change. Complications were [12%] bulla in partnehymea, [4%] plural disear, [2%] pneumothorax, and 2% died during follow up duration.
Conclusion: TLB is an effective and relatively safe, minimally invasive intervention for interstitial lung disease diagnosis. Accordingly, it must be considered a standard diagnostic tool for undiagnosed suspected cases. 

DOI

10.21608/ijma.2021.63433.1265

Keywords

Interstitial Lung Disease, Transthoracic, Lung Biopsy, Efficacy, safety

Authors

First Name

Mohamed Mustafa

Last Name

Elsheikh

MiddleName

Mahmoud

Affiliation

Department of Chest Diseases, Damietta Faculty of Medicine, Al-Azhar University, Egypt

Email

alshykhmhmd457@gmail.com

City

-

Orcid

-

First Name

Hussein Ahmad

Last Name

Abo-Elyazed

MiddleName

-

Affiliation

Department of Chest Diseases, Faculty of Medicine, Al-Azhar University, Egypt

Email

husseinaae19@gmail.com

City

Cairo

Orcid

-

First Name

Kamel

Last Name

Abdelghaffar

MiddleName

-

Affiliation

Department of Chest Diseases, Damietta Faculty of Medicine, Al-Azhar University, Egypt

Email

kamelelghonamy@domazhermedicine.edu.eg

City

Bohira Governorate

Orcid

-

First Name

Atef

Last Name

Alrifai

MiddleName

Wahdan

Affiliation

Department of Chest Diseases, Damietta Faculty of Medicine, Al-Azhar University, Egypt

Email

atefchest@gmail.com

City

Mansoura

Orcid

-

First Name

Salah Eldeen

Last Name

Semary

MiddleName

-

Affiliation

Department of Pathology, Damietta Faculty of Medicine, Al-Azhar University, Egypt

Email

-

City

-

Orcid

-

Volume

3

Article Issue

4

Related Issue

28733

Issue Date

2021-10-01

Receive Date

2021-02-15

Publish Date

2021-10-01

Page Start

1,777

Page End

1,783

Print ISSN

2636-4174

Online ISSN

2682-3780

Link

https://ijma.journals.ekb.eg/article_189868.html

Detail API

https://ijma.journals.ekb.eg/service?article_code=189868

Order

3

Type

Original Article

Type Code

816

Publication Type

Journal

Publication Title

International Journal of Medical Arts

Publication Link

https://ijma.journals.ekb.eg/

MainTitle

Assessing the Safety and Efficacy of Thoracoscopic Lung Biopsy in Patients with Interstitial Lung Disease

Details

Type

Article

Created At

22 Jan 2023